Table 6.
The advantages and potential limitations of EV therapy
| Advantages |
Lipid bilayer shell can avert proteolytic degradation; EVs contain many potential regulatory components; EVs can be applied to personalized medicine. |
[129, 132–134] |
| Potential limitations |
Short-term effects because of short half-life; Rapid clearance by the innate immune system; Efficiency of EV uptake needs to be improved; Administration routes of EVs must be appropriately selected. |
[135–138] |